)
)
George Tidmarsh
Director - Center for Drug Evaluation and Research,
U. S. Food & Drug Administration
Dr. George Tidmarsh is the Director of the Center for Drug Evaluation and Research. The Center’s mission is to ensure that safe, effective, and high-quality drugs are available to the public. To achieve this, CDER regulates the medical products under its jurisdiction throughout their lifecycle, oversees the development of new and generic drugs, evaluates applications to determine whether drugs should be approved, monitors the safety of drugs after they are marketed, conducts research to advance regulatory science, and takes enforcement actions to protect the public from harmful products.
Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development. He brings to the FDA over 30 years of experience in biotechnology, clinical medicine, and regulatory science and has authored 143 scientific publications and patents. Dr. Tidmarsh joined the FDA from Stanford University School of Medicine where he was Adjunct Professor, Pediatrics and Neonatology. He served as clinical faculty at Stanford for a number of years prior to devoting his career to clinical research and development, working to bring new treatments to patients.
As the founding co-director of Stanford’s Master of Translational Research and Applied Medicine (M-TRAM) program, Dr. Tidmarsh helped train students and researchers to bridge academic research and clinical development to translate scientific discoveries into real-world medical solutions. He has led the successful clinical development of seven FDA-approved drugs and served as founder and CEO of multiple biopharmaceutical companies focused on oncology and critical care medicine and is widely recognized for his ability to bring forward innovative treatments that address serious unmet medical needs. He has served on advisory boards across academia, government, and industry.
Dr. Tidmarsh received a B.S. in microbiology from Stanford University. He then earned his M.D. and Ph.D. in cancer biology from Stanford, where he completed residency training in pediatrics. He went on to complete two subspecialty programs at Stanford, one in pediatric oncology and another in neonatology.
){kind=logo}
)
)
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}